Clinical Trial Update: Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Velcade in combination with R-CHOP for B cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• R-CHOP
• Velcade (bortezomib)

Snippet

Sponsor: Lymphoma Study Association | Conditions: B Cell Lymphoma | Phase 2 | Status: COMPLETED